Načítá se...
2-Deoxyglucose and Beta-Hydroxybutyrate: Metabolic Agents for Seizure Control
Current anti-seizure drugs (ASDs) are believed to reduce neuronal excitability through modulation of ion channels and transporters that regulate excitability at the synaptic level. While most patients with epilepsy respond to ASDs, many remain refractory to medical treatment but respond favorably to...
Uloženo v:
| Vydáno v: | Front Cell Neurosci |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6503754/ https://ncbi.nlm.nih.gov/pubmed/31114484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2019.00172 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|